CARDIOVASCULAR OUTCOMES WITH β-BLOCKER COMBINATION TREATMENT IN PATIENTS WITH HYPERTENSION: A LARGE, RETROSPECTIVE COHORT STUDY

Brent Egan,Jan Basile,Henry Punzi, Sanjida Ali,Qian Li,Mehul Patel,Joel Neutel

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 2|浏览13

暂无评分

摘要

β-blockers (BBs) reduce cardiovascular (CV) event risk, but the comparative risk between vasodilatory (nebivolol [NEB]) and non-vasodilatory (atenolol [ATN], metoprolol [MET]) BBs is unknown. Hospitalization risk due to CV events was assessed in NEB, ATN and MET-treated patients receiving

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要